Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endocrine and Metabolic Diseases”

20,850 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20,850 results

Early research (Phase 1)Study completedNCT06469138
What this trial is testing

Investigate 14C-bemcentinib in Healthy Male Subjects

Who this might be right for
Non-Small Cell Lung CancerMetastatic MelanomaAcute Myeloid Leukemia+5 more
BerGenBio ASA 6
Post-approval studies (Phase 4)Looking for participantsNCT06291155
What this trial is testing

Mechanism of SGLT2 Inhibition in the Kidney

Who this might be right for
Type 2 DiabetesDiabetic Kidney Disease
University of Michigan 20
Not applicableStudy completedNCT05822648
What this trial is testing

Evaluating a Type 2 Diabetes Prevention Program

Who this might be right for
Type 2 DiabetesPreDiabetes
Stanford University 62
Not applicableStudy completedNCT06187285
What this trial is testing

Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia

Who this might be right for
Type 2 Diabetes
Medanta, The Medicity, India 220
Not applicableStudy completedNCT05742685
What this trial is testing

Refinement and Adaption of Reinforcement Learning to Personalize Behavioral Messaging for Healthy Habits

Who this might be right for
Diabetes Mellitus, Type 2Medication Adherence
Brigham and Women's Hospital 28
Large-scale testing (Phase 3)Study completedNCT00325117
What this trial is testing

To Assess the Efficacy and Safety of Vildagliptin as Add-on Therapy to Sulfonylurea in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea Monotherapy

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 200
Not applicableActive Not RecruitingNCT02276950
What this trial is testing

HeAlth-data Register sTudies of Risk and Outcomes in Cardiac Surgery

Who this might be right for
Cardiovascular DiseasesKidney DiseasesDepression+1 more
Ulrik Sartipy, MD, PhD 150,000
Not applicableActive Not RecruitingNCT06569290
What this trial is testing

Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches

Who this might be right for
DiabetesPharmacist-Patient RelationsMedication Adherence
Brigham and Women's Hospital 590
Not applicableStudy completedNCT07269197
What this trial is testing

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Josip Juraj Strossmayer University of Osijek 67
Not applicableStudy completedNCT00842010
What this trial is testing

Characteristics of Non Diabetic Hyperglycemic Inpatients

Who this might be right for
Diabetes Mellitus
Cook County Health 600
Testing effectiveness (Phase 2)Study completedNCT01930097
What this trial is testing

Closed-loop Control of Glucose Levels After Meal Intake in Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal 12
Post-approval studies (Phase 4)UnknownNCT04027023
What this trial is testing

Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Sciema UG 9
Testing effectiveness (Phase 2)Study completedNCT00129259
What this trial is testing

Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Allergy and Infectious Diseases (NIAID) 83
Testing effectiveness (Phase 2)Study completedNCT01030679
What this trial is testing

Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Chong Kun Dang Pharmaceutical 214
Early research (Phase 1)Study completedNCT01054118
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and Sitagliptin

Who this might be right for
Diabetes Mellitus, Type 2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 18
Post-approval studies (Phase 4)Study completedNCT02056210
What this trial is testing

Stem Cell Mobilization With Plerixafor in Diabetic vs Control Subjects

Who this might be right for
Diabetes
University of Padova 20
Not applicableUnknownNCT01178723
What this trial is testing

The Effects of Breakfast Size on Hormonal Profile in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Wolfson Medical Center 48
Not applicableStudy completedNCT04547023
What this trial is testing

Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy

Who this might be right for
Gestational DiabetesDiagnoses DiseasePregnancy in Diabetic+1 more
Stanford University 200
Not applicableStudy completedNCT03406923
What this trial is testing

Self-efficacy, Beliefs and Adherence- Pilot and Feasibility Trial of a Pharmacist-led Intervention

Who this might be right for
Diabetes Mellitus
University of Wisconsin, Madison 31
Testing effectiveness (Phase 2)Study completedNCT05351879
What this trial is testing

Evaluation of a Booster Administration of GAD-alum (Diamyd®) in Individuals With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Linkoeping University 6
Load More Results